Korea approves first anti-COVID-19 monoclonal antibody treatment

Drug Discovery |  News | 0 Comment | 08 Feb, 2021

Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...Read more

India's Biocon Biologics to offer Oncology Biosimilars in over 30 countries

Drug Discovery |  News | 0 Comment | 05 Feb, 2021

Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...Read more

Hong Kong develops formula for treating Alzheimer's disease

Drug Discovery |  News | 0 Comment | 05 Feb, 2021

Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...Read more

Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China

Drug Discovery |  News | 0 Comment | 20 Jan, 2021

Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialise...Read more

Mitsubishi Tanabe & Takeda to accelerate data-driven drug discovery

Drug Discovery |  News | 0 Comment | 19 Jan, 2021

Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that MTPC and Takeda Pharmaceutical Company...Read more

Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery

Drug Discovery |  News | 0 Comment | 12 Jan, 2021

Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...Read more

Fujifilm injects $2B into large-scale cell culture manufacturing site in US

Drug Discovery |  News | 0 Comment | 08 Jan, 2021

FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...Read more

Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China

Drug Discovery |  News | 0 Comment | 06 Jan, 2021

The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...Read more

Singapore launches spin-off to develop treatment for intractable diseases

Drug Discovery |  News | 0 Comment | 24 Dec, 2020

The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...Read more

Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets

Drug Discovery |  News | 0 Comment | 04 Dec, 2020

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...Read more

Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies

Drug Discovery |  News | 0 Comment | 01 Dec, 2020

Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...Read more

Korea's OliPass advisory board to evaluate osteoarthritis pain killer drug development

Drug Discovery |  News | 0 Comment | 25 Nov, 2020

OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...Read more

Koru Lifescience identifies drug compounds beneficial for COVID-19 trials

Drug Discovery |  News | 0 Comment | 24 Nov, 2020

New Zealand's Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, has ident...Read more

Insilico announces AI-powered drug discovery collaboration with Janssen

Drug Discovery |  News | 0 Comment | 11 Nov, 2020

Hong Kong-based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecu...Read more

Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Drug Discovery |  News | 0 Comment | 09 Nov, 2020

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...Read more

Cerecin's Tricaprilin receives ODD in the Treatment of infantile spasms

Drug Discovery |  News | 0 Comment | 30 Oct, 2020

Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the ...Read more

CStone inks deal worth $353.5M for new antibody drug conjugate

Drug Discovery |  News | 0 Comment | 29 Oct, 2020

CStone Pharmaceuticals has announced a licensing agreement with LegoChem Biosciences, Inc., (LCB) for the development an...Read more

ASLAN to develop next-gen DHODH inhibitor in autoimmune conditions

Drug Discovery |  News | 0 Comment | 16 Oct, 2020

ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...Read more